In the first installment of this four-part series on the Clinical Research in Rare Diseases, our Medics take a closer look at the developing treatments and therapeutic challenges of Adult Onset Still’s Disease (AOSD). “Adult onset Still’s disease (AOSD) is a rare inflammatory joint disease of unknown aetiology characterised by arthritis, fevers spiking once or […]

 

 

 

In this issue of our newsletter, you can read more about the Clinical Development in Rare Diseases. The first article in a four-part series regarding rare diseases. Our Medics take a closer look at treatment, therapeutic challenges and Clinical Development associated with Idiopathic Pulmonary Fibrosis (IPF): “Idiopathic pulmonary fibrosis (IPF) is a rare disease, which affects […]

 

 

 

In the final installment of this four-part series on the Clinical Development in Challenging Cancers, our Medics take a closer look at the developing treatments and therapeutic challenges of Cholangiocarcinoma (CCA): “CCA is considered to be the second most frequent primary hepatobiliary malignancy after hepatocellular carcinoma (HCC)4. Due to the uneven distribution of risk factors, […]

 

 

 

In the third article in the series. Our Medics take a closer look at treatment, therapeutic challenges and Clinical Development in Ovarian Clear Cell Carcinoma (OCCC): “Ovarian clear cell carcinoma (OCCC) is a rare histological subtype of epithelial ovarian cancers (EOCs), with an incidence, among EOCs, of 4-12% in Western countries [1–3] and a higher […]

 

 

 

In this second article of the four part series, you can read and find more information about Primary Bone Sarcomas that are considered as an extremely rare type of cancers. “Primary bone sarcomas are cancers of mesenchymal, non-epithelial derivation, originating from bone cells or their precursors. As shown in Figure 1, the most common forms […]

 

 

« Older